|
EXD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.12330170007635E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.76680001132235E-09 |
| Normal-vs-Stage2 |
2.070300E-02 |
| Normal-vs-Stage3 |
1.23620003122937E-10 |
| Normal-vs-Stage4 |
8.94895268999107E-12 |
| Stage1-vs-Stage2 |
9.903300E-03 |
| Stage1-vs-Stage3 |
3.517800E-02 |
| Stage1-vs-Stage4 |
5.244700E-04 |
| Stage2-vs-Stage3 |
3.016000E-04 |
| Stage2-vs-Stage4 |
1.89728999999694E-05 |
| Stage3-vs-Stage4 |
2.087800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54849466582618E-11 |
| Normal-vs-AfricanAmerican |
2.247700E-04 |
| Normal-vs-Asian |
2.26509999999847E-05 |
| Caucasian-vs-AfricanAmerican |
6.839800E-01 |
| Caucasian-vs-Asian |
3.569000E-01 |
| AfricanAmerican-vs-Asian |
7.944400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.45149489386654E-11 |
| Normal-vs-Female |
1.21220000703914E-09 |
| Male-vs-Female |
1.170000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.23279999939297E-09 |
| Normal-vs-Age(41-60Yrs) |
3.69449999482185E-08 |
| Normal-vs-Age(61-80Yrs) |
1.17270004817982E-09 |
| Normal-vs-Age(81-100Yrs) |
9.787500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.824600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.557400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.199800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.709000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.807200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.018800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.219130E-04 |
| Classical-VS-Follicular |
2.924200E-01 |
| Classical-VS-Other |
9.660800E-01 |
| Classical-VS-Normal |
5.96110050210541E-10 |
| Tall-VS-Follicular |
1.197010E-04 |
| Tall-VS-Other |
3.070000E-01 |
| Tall-VS-Normal |
1.48769885299771E-11 |
| Follicular-VS-Other |
7.714200E-01 |
| Follicular-VS-Normal |
1.004270E-04 |
| Other-VS-Normal |
4.045700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.95100000044413E-07 |
| Normal-vs-N1 |
1.19209975224521E-10 |
| N0-vs-N1 |
8.578300E-03 |
|
|
